Types of insulin include short-acting, rapid-acting, intermediate-acting, long-acting, ultra-long-acting, and inhaled. Here's which is best for you.

Treatment with once-weekly IcoSema demonstrated noninferiority in HbA1c reduction at week 52 compared with insulin glargine and aspart. Treatment with once-weekly IcoSema, a fixed-ratio combination of ...

Share on Pinterest Mounjaro appears to be a safe and effective adjunct therapy to slow-release insulin for treating uncontrolled diabetes. Mohammed Al Ali/Shutterstock Tirzepatide, Mounjaro, is ...

Insulin efsitora alfa (efsitora) is a new basal insulin designed for once-weekly administration. Data on safety and efficacy have been limited to small, phase 1 or phase 2 trials. We conducted a ...

Nearly 39 million American adults are currently living with diabetes, the latest data shows — and between 90% and 95% of those cases are type 2 diabetes. Type 1 diabetes, although it only makes up 5% ...

Obesity and type 2 diabetes are complex metabolic disorders linked to insulin resistance in skeletal muscle. Weight loss, a fundamental treatment for these conditions, has been shown to improve ...

Diabetes affects 37 million people in the U.S. The Centers for Disease Control and Prevention estimates another 96 million people – or 1 in 3 adults – have prediabetes, a condition where blood sugar ...

BAGSVÆRD, Denmark and PLAINSBORO, N.J., Sept. 29, 2025 /PRNewswire/ -- Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration ...